FIELD: medicine, combined therapy.
SUBSTANCE: invention relates to pharmaceutical composition for endothelial tumor treatment containing in therapeutically effective amount antiangiogenic agent such as polypeptide including RGD sequence namely cyclo(Arg-Gly-Asp-Dphe-NmeVal) and tumor necrosis factor TNFα. Also disclosed are kit containing pharmaceutical composition, application of abovementioned pharmaceutical composition and kit, and method for therapy.
EFFECT: agent for effective treatment of endothelial tumors.
15 cl, 16 ex, 8 dwg
Authors
Dates
2008-02-10—Published
2002-04-18—Filed